The Opportunities and Challenges of Metabolomics Biomarkers Discovery and Development in Clinical Diagnostics
Huafen Liu | Founder and President
Calibra Diagnostics | China
Abstract: Metabolomics is a series of systematic analysis of endogenous metabolites in biological samples. To improve the clinical course of diseases, prevention and precision, clinical diagnostics are desired. In order to achieve this, metabolomics offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional clinical diagnostics. It is critical to have reliable and consistent data for product development. This presentation will highlight the opportunities and challenges of Metabolomics biomarkers discovery and development in clinical diagnostics.
During this webinar, you will learn about:
- Key challenges and opportunities
- Reliable data and internal standard importance in untargeted biomarker discovery and product development
- Regulation requirement for In Vitro Diagnostic (IVD) Multivariate Assay
A transcript of this presentation is available in English here.